Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension: Results From a Controlled Before and After Study
Journal Title: International Journal of Cardiology and Research (IJCRR) - Year 2016, Vol 3, Issue 2
Abstract
Background: Pulmonary arterial hypertension (PAH) is a severe disease. 6-minute walk distance (6MWD) is correlated with the prognosis of PAH patients. We previously reported the safety and efficacy of pulmonary artery denervation (PADN) for patients with idiopathic PAH (IPAH) who were unresponsive to target drugs. However, PADN has not been tested in a well-designed study for patients with IPAH/PAH or pulmonary hypertension (PH). Objectives: The present study aimed to analyze the difference in 6-minute walk distance (6MWD) at 6-month after PADN and standard pharmacotherapy. Methods: Between February 2013 and June 2014, a total of 28 patients with IPAH (n=11), PH from left heart disease (n=8), and 9 secondary PAH were included in this study. A wash-out consisting of 5 half-lives for target drugs was performed for all the patients. Next, medications were prescribed for a 6-month duration for the patients (Medication treatment). A second wash-out (5 half-lives) was completed for all the patients after the 6-month medication treatment. Finally, PADN was performed for these patients (PADN treatment), and an additional 6-month follow-up period was completed. The primary endpoint was the difference in the ∆6MWD (defined as value at 6-month minus baseline) between two treatments. Results: After 6-month treatment, there was significant difference in the ∆6MWD between PADN (65±85 m) and Medication (13±24 m) treatment (95% CI -21.34-3.49, p=0.002), coupling with the differences in the reduction of systolic pulmonary artery pressure (PAP, -13.75±14.1 mmHg vs. -0.46±3.47 mmHg, p<0.001), mean PAP (-7.86±6.10 mmHg vs. -0.14±2.48 mmHg, p<0.001), mean right atrial pressure (-2.53±3.75 mmHg vs. -0.21±2.62 mmHg, p=0.007), and pulmonary vessel resistance (-4.59±7.06 Woods unit vs. -0.17±2.56 Woods unit, p=0.001). PADN treatment was associated with less frequent 6-month PAH-related event (10.8%), compared to 42.9% in Medication treatment (p=0.005). Conclusion: The present study showed that PADN treatment was associated with significant improvement of 6MWD and less PAH-related event. Further study was required to show the benefit of PADN in reducing mortality in patients with IPAH and secondary PAH.
Authors and Affiliations
Shao-Liang Chen
Keywords
Related Articles
- EP ID EP206510
- DOI 10.19070/2470-4563-1600012
- Views 106
- Downloads 0
Iatrogenic Right Sided Infective Endocarditis in Children with CHD
Background: Right sided endocarditis (IE) occurs predominantly in intravenous drug abusers, and occasionally acquired in hospital as a result of contaminated intravascular devices. The iatrogenic IE of tricuspid valve in...
Unprotected Distal LMCA Angioplasty with Simulataneous Kissing Stent (SKS) Technique in Left Dominant Coronary Circulation: A Nightmare for Interventionist
Left main coronary artery stenosis is the most challenging lesion in patients with acute coronary syndromes. Since the amount of myocardium at risk is very high, the patient is often in cardiogenic shock, and the risk of...
Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension: Results From a Controlled Before and After Study
Background: Pulmonary arterial hypertension (PAH) is a severe disease. 6-minute walk distance (6MWD) is correlated with the prognosis of PAH patients. We previously reported the safety and efficacy of pulmonary artery de...
Current Approach To Pulmonary Embolism
Aims: We planned to provide a systematic review of catheter-based therapies in acute pulmonary embolism (PE). Methods and Results: Studies published in peer-reviewed journals before January 2018 were included and categ...
Idiopathic Giant Cell Myocarditis - A Case Report
Sudden cardiac death is an unexpected death from cardiac causes; early after the symptom onset or even without any symptoms [1]. This case report is on a non-atherosclerotic cause of sudden cardiac death. An young adult...